Fig. 3From: Detection of HER2 expression using 99mTc-NM-02 nanobody in patients with breast cancer: a non-randomized, non-blinded clinical trial18F-FDG PET/CT and 99mTc-NM-02 SPECT/CT imaging of three patients with breast cancer (red arrows) and chest inflammation (green arrows) at 1Ā h post-injectionBack to article page